PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

All FDA drug approvals not created equal

2014-01-22
(Press-News.org) Contact information: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
All FDA drug approvals not created equal Many patients and physicians assume that the safety and effectiveness of newly approved drugs is well understood by the federal Food and Drug Administration (FDA) —but a new study by researchers at Yale School of Medicine shows that the clinical trials used by the FDA to approve new drugs between 2005 and 2012 vary widely in their thoroughness.

Published in the Jan. 22/29 issue of JAMA, the study is the first systematic analysis of the standard used by the FDA in making drug approval decisions.

"We found that during the study period, more than one-third of the drugs were approved on the basis of a single trial, without replication, and many other trials were small, short, and focused on lab values, or some other surrogate metric of effect, rather than clinical endpoints like death," said first author and Yale School of Medicine student Nicholas S. Downing, who conducted the study with senior author Joseph Ross, M.D., and colleagues at the Yale Center for Outcomes Research & Evaluation (CORE).

Downing and the team evaluated the strength of clinical trial evidence supporting FDA approval decisions for new drugs by characterizing key features of efficacy trials, such as trial size, design duration, and end points. They used publicly available FDA documents to identify 188 novel therapeutic agents for seven years. These medical review documents summarized in great detail the rationale behind FDA approvals.

"Based on our analysis, some drugs are approved on the basis of large, high-quality clinical trials, while others are approved based on results of smaller trials," said Ross, assistant professor of internal medicine at Yale School of Medicine. "There was a lack of uniformity in the level of evidence the FDA used."

He added: "We also found that only 40% of drug approvals involved a clinical trial that compared a new drug to existing treatment offerings. This is an important step for determining whether the new drug is a better option than existing, older drugs."

Downing said survey data shows that patients expect drugs approved by the FDA to be both safe and effective. "Based on our study of the data, we can't be certain that this expectation is necessarily justified, given the quantity and quality of the variability we saw in the drug approval process," he said.

### Other authors on the study include Jenerius A. Aminawung, M.D., Nilay D. Shah, and Harlan M. Krumholz, M.D.

The study was funded in part by the Pew Charitable Trusts.

Citation: JAMA doi: 10.1001/jama.2013.282034


ELSE PRESS RELEASES FROM THIS DATE:

Hedges and edges help pigeons learn their way around

2014-01-22
Hedges and edges help pigeons learn their way around A study has found that homing pigeons' ability to remember routes depends on the complexity of the landscape below, with hedges and boundaries between urban and rural areas ...

Large amounts of folic acid shown to promote growth of breast cancer in rats

2014-01-22
Large amounts of folic acid shown to promote growth of breast cancer in rats Role of folate in development, progression of breast cancer highly controversial TORONTO, Jan. 21, 2014---Folic acid supplements at levels consumed by breast cancer patients and survivors ...

Cochrane Review of dihydroartemisinin-piperaquine

2014-01-22
Cochrane Review of dihydroartemisinin-piperaquine Cochrane review of dihydroartemisinin-piperaquine for treating uncomplicated malaria 'Dihydroartemisinin-piperaquine is more effective than artemether-lumefantrine, and has fewer side effects than artesunate-mefloquine' ...

Researchers identify innate channel that protects against pain

2014-01-22
Researchers identify innate channel that protects against pain Scientists have identified a channel present in many pain detecting sensory neurons that acts as a 'brake', limiting spontaneous pain. It is hoped that the new research, published today ...

Study: Electric drive vehicles have little impact on US pollutant emissions

2014-01-22
Study: Electric drive vehicles have little impact on US pollutant emissions A new study from North Carolina State University indicates that even a sharp increase in the use of electric drive passenger vehicles (EDVs) by 2050 would not significantly reduce ...

Study: 'Icy' technique improves robotic kidney transplants

2014-01-22
Study: 'Icy' technique improves robotic kidney transplants DETROIT – A collaboration of surgeons at Henry Ford Hospital and Medanta Hospital in India successfully transplanted kidneys into 50 recipients using an innovative robot-assisted procedure in which ...

More diseases from air pollution uncovered by improved data material

2014-01-22
More diseases from air pollution uncovered by improved data material At rest, we breathe approx. 12-15 times per minute, and for each inhalation we change approx. one litre of air. Depending on the activity level, this makes up a daily quantity in the order of twenty cubic metres ...

Understanding the functioning of a new type of solar cell

2014-01-21
Understanding the functioning of a new type of solar cell Photovoltaic energy conversion offers one of the best means for the future of renewable energy in the world. The efficiency of solar cells depends heavily upon the light-absorbing materials ...

DNA barcodes change our view on how nature is structured

2014-01-21
DNA barcodes change our view on how nature is structured How you seek is what you find To understand how feeding interactions are structured, researchers from Finland and Canada chose to focus on one of the simplest food webs on Earth: the moths and butterflies ...

Quality control of mitochondria as a defense against disease

2014-01-21
Quality control of mitochondria as a defense against disease HEIDELBERG, 20 January 2014 – Scientists from the Montreal Neurological Institute and Hospital in Canada have discovered that two genes linked to hereditary Parkinson's disease are ...

LAST 30 PRESS RELEASES:

Scientists develop an efficient method of producing proteins from E. coli

AAAS announces addition of Cancer Communications to Science Partner Journal Program

Systematic review reveals psilocybin reduces obsessive-compulsive behaviors across clinical and preclinical evidence

Emerging roles of neuromodulation in the management of treatment-resistant OCD

All prey are not the same: marine predators face uneven nutritional payoffs

What drives sleep problems in long-term care facilities?

New antibiotic for drug-resistant bacteria found hiding in plain sight

New mapping identifies urgent opportunities to strengthen Singapore’s children’s mental health ecosystem

New research reveals significant prevalence of valvular heart disease among older Americans

Outdoor air pollution linked to higher incidence of breast cancer

Thiophene-doped fully conjugated covalent organic frameworks for efficient photocatalytic hydrogen peroxide production

Earth’s ‘boring billion years’ created the conditions for complex life

Health data for 57 million people in England show changing patterns of heart diseases before, during and after the pandemic

Cycling ‘near misses’ in London worst at rush hour and on roads without dedicated infrastructure

Roots in the dark: Russian scientists uncover hidden carbon dioxide uptake in plant roots

Biochar and hydrochar show contrasting climate effects in boreal grasslands

Turning trash into treasure: Scientists transform waste plastics into high-value carbon materials

Boys don’t cry? How picture books can teach gendered ideas about pain

In global collaboration, IU scientists unlock secrets to the building blocks of the universe

Young adults fear mass shootings but don’t necessarily support gun control

How unlocking ‘sticky’ chemistry may lead to better, cleaner fuels

Cutting balloon treatment prior to stent placement comparable to intravascular lithotripsy for patients with calcified coronary artery disease

Novel sirolimus-eluting balloon appears noninferior to conventional therapies for treatment of in-stent restenosis

Nearly half of US workers don’t know work experience could count toward a degree, according to University of Phoenix survey

Super-high-pressure non-compliant balloons for treatment of calcified coronary lesions noninferior to intravascular lithotripsy

Saudi Native Dr. Hani K. Najm named next vice president of the American College of Cardiology

Getting steps in one long walk a day cuts risk of death and CVD better than multiple short walks

The way you walk: 10–15 minute bouts of walking better for your cardiovascular health than shorter strolls

Beyond electronics: harnessing light for faster computing

Researchers find possible cause for increasing polarization

[Press-News.org] All FDA drug approvals not created equal